Commission Regulation (EU) No 1017/2013 of 23 October 2013 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health Text with EEA relevance

• CELEX: Regulation (EU) No 1017/2013
• Articles: 3

Article 1

1.   The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.

2.   However, the health claims referred to in paragraph 1 used prior to the entry into force of this Regulation, may continue to be used for a maximum period of six months after the entry into force of this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Rejected health claims

Application – Relevant provisions of Regulation (EC) No 1924/2006

Nutrient, substance, food or food category

Claim

EFSA opinion reference

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

‘Hypo-caloric snacks (KOT products)’

Contributes to reduce the adipocytes size at the abdominal level, in the context of a low-calorie diet

Q-2011-00016

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP)

Peptides IPP and VPP help to maintain normal blood pressure

Q-2011-00121

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Appl’In® polyphenolic apple extract powder ( Malus domestica )

Appl’In® contributes to decrease glycaemic response in women

Q-2011-00190

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Coffee C21

Regular consumption of Coffee C21 contributes to the maintenance of DNA integrity in cells of the body

Q-2011-00783

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Diacylglycerol (DAG) oil

Substituting your usual vegetable oil with DAG oil helps in the management of body weight through weight loss

Q-2011-00751

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Spermidine

Spermidine prolongs the growing phase (anagen) of the hair cycle

Q-2011-00896

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Bimuno® (Bimuno® GOS)

Regular daily consumption of 1,37 g galacto-oligosaccharides from Bimuno® may reduce intestinal discomfort

Q-2011-00401

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Sugar beet fibre

Sugar beet fibre decreases intestinal transit time

Q-2011-00971